Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations

Calgary, Alberta – TheNewswire - November 5, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology, today announced encouraging one-month results from all patients in Group 1 of its first-in-human clinical study evaluating the Ocumetics Accommodating Intraocular Lens (the “Ocumetics Lens”). Ocumetics completed Group 1 surgeries in August 2025 (“Day 1”) and completed additional Group 1 surgeries in September ...